Jade Biosciences Inc (JBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,910 | -22,963 | -14,740 | -8,556 | -2,781 |
| Depreciation Amortization | 40 | 31 | 7 | 4 | 2 |
| Accounts payable and accrued liabilities | 1,587 | 609 | 1,654 | 563 | 765 |
| Other Working Capital | 4,185 | -6,510 | -762 | 428 | -1,019 |
| Other Operating Activity | -563 | 1,434 | -465 | -219 | -742 |
| Operating Cash Flow | $-5,661 | $-27,399 | $-14,306 | $-7,780 | $-3,775 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -20,371 | -113,253 | N/A | N/A | N/A |
| PPE Investments | -28 | -181 | -96 | -40 | -40 |
| Investing Cash Flow | $-20,399 | $-113,434 | $-96 | $-40 | $-40 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 126,945 | 127,195 | N/A | N/A |
| Other Financing Activity | 0 | 63,512 | 63,512 | 62,397 | 7,883 |
| Financing Cash Flow | $0 | $190,457 | $190,707 | $62,397 | $7,883 |
| Beginning Cash Position | 54,197 | 4,573 | 4,573 | 4,573 | 4,573 |
| End Cash Position | 28,137 | 54,197 | 180,878 | 59,150 | 8,641 |
| Net Cash Flow | $-26,060 | $49,624 | $176,305 | $54,577 | $4,068 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,661 | -27,399 | -14,306 | -7,780 | -3,775 |
| Capital Expenditure | -28 | -181 | -96 | -40 | -40 |
| Free Cash Flow | -5,689 | -27,580 | -14,402 | -7,820 | -3,815 |